Skip to main content
SpringerLink
Log in

Alcohol and Drug Interactions

  • Chapter
Handbook of Drug Interactions

Part of the book series: Forensic Science and Medicine ((FSM))

  • 505 Accesses

Abstract

Drug interactions involving alcoholl constitute a major problem in clinical and forensic medicine owing to the widespread use and abuse of alcoholic beverages throughout adult life (1–3). The combined effects of alcohol and other drugs acting on the central nervous system (CNS) are particularly dangerous and have accounted for many fatal poisonings both accidental and through deliberate suicide attempts (4–8). Adverse drug interactions are a constant concern for the pharmaceutical industry whenever a new drug is marketed and such possibilities need to be carefully explored in both human and animal studies (9,10).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dhossche DM, Rich CL, and Isacsson G. Psychoactice substances in suicides: comparison of toxicologic findings in two samples. Am J Forens Med Pathol 22:239–243 (2001).

    CAS  Google Scholar 

  2. Heninger MM. Commonly encountered prescription medications in medical-legal death investigations: a guide for death investigators and medical examiners. Am J Forens Med Pathol 21:287–299 (2000).

    CAS  Google Scholar 

  3. Alsén M, Ekedahl A, Löwenhielm P, Niméus A, Regnell G, and Träskman-Bendz L. Medicine self-poisoning and the sources of drugs in Lund, Sweden. Acta Psychiat Scand 89: 255–261 (1994).

    PubMed  Google Scholar 

  4. Prescott LF and Highley MS. Drugs prescribed for self-poisoners. Br Med J 290:1633–1636 (1985).

    CAS  Google Scholar 

  5. Lazarou J, Pomeranz BH, and Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 279:1200–1205 (1998).

    CAS  PubMed  Google Scholar 

  6. Buajordet I, Ebbesen J, Erikssen J, Brors O, and Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 250:327–341 (2001).

    CAS  PubMed  Google Scholar 

  7. Osselton MD, Blackmore RC, King LA, and Moffat AC. Poisoning associated deaths for England and Wales between 1973–1980. Hum Toxicol 3:201–221 (1984).

    CAS  PubMed  Google Scholar 

  8. Rivara FP, Mueller BA, Somes G, Menoza CT, Rushforth NB, and Kellermann AL. Alcohol and illicit drug abuse and the risk of violent death in the home. JAMA 278:569–575 (1997).

    CAS  PubMed  Google Scholar 

  9. Edwards IR and Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 356:1255–1259 (2000).

    CAS  PubMed  Google Scholar 

  10. Lasser KE, Allen PD, Woodhandler SJ, Himmelstein DU, Wolfe SM, and Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA 287: 2215–2220 (2002).

    PubMed  Google Scholar 

  11. Sjogren H, Eriksson A, and Ahlm K. Role of alcohol in unnatural deaths: a study of all deaths in Sweden. Alcohol Clin Exp Res 24:1050–1056 (2000).

    CAS  PubMed  Google Scholar 

  12. Cox DE, Sadler DW, and Pounder DJ. Alcohol estimation at necropsy: epidemiology, economics, and the elderly. J Clin Pathol 50:197–201 (1997).

    CAS  PubMed  Google Scholar 

  13. Pentilla A, Karhunen PJ, and Vuori E. Blood alcohol in sudden and unexpected deaths. Forens Sci Intern 43:96–102 (1989).

    Google Scholar 

  14. Roche AM, Watt K, McClure R, Purdi DM, and Green D. Injury and alcohol: a hospital emergency department study. Drug & Alc Rev 20:155–166 (2001).

    Google Scholar 

  15. White IR, Altmann DR, and Nanchahal K. Alcohol consumption and mortality: modelling risks for men and women at different ages. Br Med J 325:191–194 (2002).

    Google Scholar 

  16. Neutel CI. Risk of traffic accidents injury after a prescription for a benzodiazepine. Ann Epidemiol 5:239–244 (1995).

    CAS  PubMed  Google Scholar 

  17. Skurtveit S, Abotnes B, and Christophersen AS. Drugged drivers in Norway with benzodiazepine detection. Forens Sci Intern 125:75–82 (2002).

    CAS  Google Scholar 

  18. Ropero-Miller JD and Goldberger BA. Recreational drugs—current trends in the 90s. Clin Lab Med 18:727–746 (1998).

    CAS  PubMed  Google Scholar 

  19. Jones AW. Enforcement of drink-driving laws by use of “per se” legal alcohol limits: blood and/or breath concentration as evidence of impairment. Alc Drugs Driving 4:99–112 (1988).

    Google Scholar 

  20. Jones AW. Medicolegal alcohol determinations-Blood- or breath-alcohol concentration? Forens Sci Rev 12:23–48, 2000.

    Google Scholar 

  21. Ferner RE. Forensic pharmacology: medicines, mayhem and malpractice. Oxford, England: Oxford University Press, 1996:1–236.

    Google Scholar 

  22. Jones AW. Top-ten defense challenges among drinking drivers in Sweden. Med Sci Law 31:429–439 (1991).

    CAS  Google Scholar 

  23. Ito K, Iwatsubo T, Kanamitsu S, Ueda K, Suzuki H, and Sugiyama Y. Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interactions in the liver. Pharmacol Rev 50:335–492 (1998).

    Google Scholar 

  24. Seppala T, Linnoila M, and Mattila MJ. Drugs, alcohol and driving. Drugs 17:389–408 (1979).

    CAS  PubMed  Google Scholar 

  25. Sellers EM and Holloway MR. Drug kinetics and alcohol ingestion. Clin Pharmacokinet 3:440–452 (1978).

    CAS  PubMed  Google Scholar 

  26. Griffin JP. Drug interactions occurring during absorption from the gastrointestinal tract. Pharmacol Ther 15:79–88 (1981).

    CAS  PubMed  Google Scholar 

  27. Sitar DS. Human drug metabolism in vivo. Pharmacol Ther 43:363–375 (1989).

    CAS  PubMed  Google Scholar 

  28. Mezey E. Ethanol metabolism and ethanol-drug interactions. Biochem Pharmacol 25: 869–874 (1976).

    CAS  PubMed  Google Scholar 

  29. Offerhaus L. Drug interactions at excretory mechanisms. Pharmacol Ther 15:69–78 (1981).

    CAS  PubMed  Google Scholar 

  30. Orrenius S. Alcohol and drug interactions; basic concepts. In: Lieber CS, ed. Recent advances in the biology of alcoholism, Vol. 1, New York: Haworth, 1981:25–40.

    Google Scholar 

  31. Linnoila M, Mattila MJ, and Kitchell BS. Drug interactions with alcohol. Drugs 18:299–311 (1979).

    CAS  PubMed  Google Scholar 

  32. Lieber CS. Interaction of alcohol with other drugs and nutrients: implications for the therapy of alcoholic liver disease. Drugs 40(Suppl 3):23–44 (1990).

    CAS  PubMed  Google Scholar 

  33. Bloor JH, Mapoles JE, and Simon FR. Alcoholic liver disease: new concepts of pathogenesis and treatment. Adv Intern Med 39:49–92 (1994).

    CAS  PubMed  Google Scholar 

  34. Hoyumpa AM and Schenker S. Major drug interactions: effect of liver disease, alcohol, and malnutrition. Ann Rev Med 33:113–149 (1982).

    CAS  PubMed  Google Scholar 

  35. Howden CW, Birnie GG, and Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther 40:439–474 (1989).

    CAS  PubMed  Google Scholar 

  36. McLean AJ and Morgan DJ. Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet 231:42–69 (1991).

    Google Scholar 

  37. Sonne J. Drug metabolism in liver disease. Implications for therapeutic drug monitoring. Therap Drug Monitor 18:397–401 (1996).

    CAS  Google Scholar 

  38. Mattila MJ. Alcohol and drug interactions. Ann Med 22:363–369 (1990).

    CAS  PubMed  Google Scholar 

  39. Kalant H, LeBlanc SE, and Gibbins RJ. Tolerance to and dependence on some non-opiate psychotropic drugs. Pharmacol Rev 23:135–191 (1971).

    CAS  PubMed  Google Scholar 

  40. Chesher G and Greeley J. Tolerance to the effects of alcohol. Alc Drugs Driving 8:93–106 (1992).

    Google Scholar 

  41. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 319:1639–1650 (1988).

    CAS  PubMed  Google Scholar 

  42. Lieber CS. Mechanism of ethanol induced hepatic injury. Pharmacol Ther 46:1–41 (1990).

    CAS  PubMed  Google Scholar 

  43. Lieber CS. Hepatic, metabolic and nutritional disorders of alcoholism: from pathogenesis to therapy. Crit Rev Clin Lab Sci 37:551–584 (2000).

    CAS  PubMed  Google Scholar 

  44. Forney RB and Hughes FW. Combined effects of alcohol and other drugs. Springfield, IL: Charles C. Thomas Publisher, 1968.

    Google Scholar 

  45. Pirola RC. Drug metabolism and alcohol. Baltimore: University Park Press, 1978.

    Google Scholar 

  46. Milner G. Drugs and driving. Basel, Switzerland: S. Karger, 1972.

    Google Scholar 

  47. Mattila MJ, ed. Alcohol, drugs and driving. Basel, Switzerland: S. Karger, 1976.

    Google Scholar 

  48. Morland J. Driving under the influence of non-alcohol drugs. Forensic Sci Rev 12:79–105 (2000).

    Google Scholar 

  49. Hemmelgaran B, Suissa S, Huang A, Boivin J-F, and Pinard G. Benzodiazepine use and the risk of motor vehicle crashes in the eldery. JAMA 278:27–31 (1997).

    Google Scholar 

  50. Sands BE, Knapp CM, and Ciraulo A. Medical consequences of alcohol-drug interactions. Alc Health Res World 17:316–320 (1993).

    Google Scholar 

  51. Lane EA, Guthrie S, and Linnoila M. Effects of ethanol on drug metabolite pharmacokinetics. Clin Pharmacokinet 10:228–247 (1985).

    CAS  PubMed  Google Scholar 

  52. Fraser AG. Pharmacokinetic interactions between alcohol and other drugs. Clin Pharmacokinet 33:79–90 (1997).

    CAS  PubMed  Google Scholar 

  53. Monroe ML and Doering PL. Effect of common over-the-counter medications on blood alcohol levels. Ann Pharmacother 35:918–924 (2001).

    CAS  PubMed  Google Scholar 

  54. Weathermon R and Crabb DW. Alcohol and medication interactions. Alc Res Health 23: 40–54 (1999).

    CAS  Google Scholar 

  55. Morland J, Bodd E, and Gadeholt G. Interaction of ethanol and drug metabolism. In: Crow KE and Batt RT, eds. Human metabolism of alcohol, Vol III. Boca Raton, FL: CRC Press, 1982:141–160.

    Google Scholar 

  56. Havier RG. The interaction of ethanol with drugs. Forensic Sci Rev 3:41–56 (1991).

    Google Scholar 

  57. Drummer OH and Odell M. Forensic pharmacology of drugs of abuse. London: Arnold, 2001.

    Google Scholar 

  58. Sands BF, Knapp CM, and Ciraulo DA. Interaction of alcohol with therapeutic drugs and drugs of abuse. Chapter 19 In: Kranzler HR, ed. The pharmacology of alcohol abuse. Berlin: Springer Verlag, 1995:475–512.

    Google Scholar 

  59. Baselt RC. Drug effects on psychomotor performance. Foster City, CA: Biomedical Publications, 2001.

    Google Scholar 

  60. Starmer GA and Bird KD. Investigating drug-alcohol interactions. Br J Clin Pharmacol 18:27S–35S (1984).

    PubMed  Google Scholar 

  61. Kelly TH, Foltin RW, Emurian CS, and Fischman MW. Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol and diazepam. J Anal Toxicol 17:264–272 (1993).

    CAS  PubMed  Google Scholar 

  62. Irving A and Jones W. Methods for testing impairment of driving due to drugs. Eur J Clin Pharmacol 43:61–66 (1992).

    CAS  PubMed  Google Scholar 

  63. Kelly M, Myrsten AL, Neri A, and Rydberg U. Effects and after-effects of alcohol on psychological and physiological functions in man. Blutalkohol 7:422–436 (1970).

    Google Scholar 

  64. Hrobjartsson A and Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344:1594–1602 (2001).

    CAS  PubMed  Google Scholar 

  65. Moskowitz H and Fiorentino D. A review of the scientific literature regarding the effects of alcohol on driving-related behavior at blood alcohol concentrations of 0.08 grams per deciliter and lower. Washington, DC: U.S. Department of Transportation, National Highway Traffic Safety Administration, 2000.

    Google Scholar 

  66. Kennedy RS, Turnage JJ, Wilkes RL, and Dunlap WP. Effects of graded dosages of alcohol on nine computerized repeated-measures tests. Ergonomics 36:1195–1222 (1993).

    CAS  PubMed  Google Scholar 

  67. Kunsman GW, Manno JE, Manno BR, Kunsman CM, and Przekop MA. The use of micro-computer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasisi on temazepine. Br J Clin Pharmacol 34:289–301 (1992).

    CAS  PubMed  Google Scholar 

  68. Törnros J, Viklander B, Ahlner J, and Jönsson K-A. Simulated driving performance of benzodiazepine users. J Traffic Med 29:4–15 (2001).

    Google Scholar 

  69. Robbe HWJ and O’Hanlon JF. Marijuana, alcohol and actual driving performance. Washington, DC: U.S. Department of Transportation, National Highway Traffic Safety Administration, DOT HS 808 939, 1999.

    Google Scholar 

  70. Farrell L and Logan BK, eds. The effects of drugs on human performance. Forensic Sci Rev 14:1–151 (2002).

    Google Scholar 

  71. Kalant H. Pharmacokinetics of ethanol: absorption, distribution, and elimination. In: Begleiter H and Kissin B, eds. The pharmacology of alcohol and alcohol dependence. Oxford & New York: Oxford University Press, 1996:15–58.

    Google Scholar 

  72. Ramchandani VA, Bosron WF, and Li T-K. Research advances in ethanol metabolism. Pathol Biol 49:676–682 (2001).

    CAS  PubMed  Google Scholar 

  73. Widmark EMP. Principles and applications of medicolegal alcohol determination. Davis, CA: Biomedical Publications, 1981.

    Google Scholar 

  74. Berggren SM and Goldberg L. The absorption of ethyl alcohol from the gastrointestinal tract as a diffusion process. Acta Physiol Scand 1:245–270 (1940).

    Google Scholar 

  75. Holt S. Observations on the relation between alcohol absorption and the rate of gastric emptying. Can Med Assoc J 124:267–277 (1981).

    CAS  PubMed  Google Scholar 

  76. Winek CL, Wahba WW, and Dowdell JL. Determinatiuon of absorption time of ethanol in social drinkers. Forens Sci Intern 77:169–177 (1996).

    CAS  Google Scholar 

  77. Jones AW, Jönsson KA, and Neri A. Peak blood-ethanol concentration and the time of its occurrence after rapid drinking on an empty stomach. J Forensic Sci 36:376–385 (1991).

    CAS  PubMed  Google Scholar 

  78. Schwartz JG, Salman UA, McMahan CA, and Phillips WT. Gastric emptying of beer in Mexican-Americans compared with non-Hispanic whites. Metabolism 45:1174–1178 (1996).

    CAS  PubMed  Google Scholar 

  79. Roine RP, Gentry RT, Lim RT, Baraona E, and Lieber CS. Effect of concentration of ingested ethanol on blood alcohol levels. Alcohol Clin Exp Res 15:734–738 (1991).

    CAS  PubMed  Google Scholar 

  80. Roine RP, Gentry RT, Lim RT, Heikkonen E, Salaspuro M, and Lieber CS. Comparison of blood alcohol concentration after beer and whiskey. Alcohol Clin Exp Res 17:709–711 (1993).

    CAS  PubMed  Google Scholar 

  81. Welling PG. Effects of food on drug absorption. Ann Rev Nutr 16:383–415 (1996).

    CAS  Google Scholar 

  82. Welling PG. Pharmacokinetics of alcohol following single low doses to fasted and nonfasted subjects. J Clin Pharmacol 17:199–206 (1977).

    CAS  PubMed  Google Scholar 

  83. Singh BN. Effects of food on clinical pharmacokinetics. Clin Pharmacokinet 37:213–255 (1999).

    CAS  PubMed  Google Scholar 

  84. Schultz J, Weiner H, and Wetscott J. Retardation of ethanol absorption by food in the stomach. J Stud Alcohol 41:861–870 (1980).

    Google Scholar 

  85. Cortot A, Jobin G, Ducrot F, Aymes C, Giraudeaux V, and Modigliani R. Gastric emptying and gastrointestinal absorption of alcohol ingested with a meal. Dig Dis Sci 31:343–348 (1986).

    CAS  PubMed  Google Scholar 

  86. Jones AW and Jönsson KKA. Food-induced lowering of blood-ethanol profiles and increased rate of elimination immediately after a meal. J Forensic Sci 39:1084–1093 (1994).

    CAS  PubMed  Google Scholar 

  87. Jones AW, Jönsson K-A, and Kechagias S. Effect of high-fat, high-protein and high-carbohydrate meals on the pharmacokinetics of a small dose of alcohol. Br J Clin Pharmacol 44:521–526 (1997).

    CAS  PubMed  Google Scholar 

  88. Ramchandani VA, Kwo PY, and Li T-K. Effect of food and food composition on alcohol elimination rates in healthy men and women. J Clin Pharmacol 41:1345–1350 (2001).

    CAS  PubMed  Google Scholar 

  89. Sedman AJ, Wilkinson PK, Sakmar DJ, Weidler DJ, and Wagner JG. Food effects on absorption and metabolism of alcohol. J Stud Alcohol 37:1197–1214 (1976).

    CAS  PubMed  Google Scholar 

  90. Pikaar NA, Wedel M, and Heemus RJJ. Influence of several factors on blood alcohol concentrations after drinking alcohol. Alc Alcohol 23:289–297 (1988).

    CAS  Google Scholar 

  91. McFarlane A, Pooley L, Welch IML, Rumsey RDE, and Read NW. How does dietary lipid lower blood alcohol concentrations? Gut 27:15–18 (1986).

    CAS  PubMed  Google Scholar 

  92. Rogers JO, Smith J, Starmer GA, and Whitfield J. Differing effects of carbohydrate fat and protein on the rate of ethanol metabolism. Alc Alcohol 22:345–353 (1987).

    CAS  Google Scholar 

  93. Wagner JG and Patel JA. Variations in absorption and elimination rates of ethyl alcohol in a single subject. Res Comm Chem Pathol Pharmacol 4:61–76 (1972).

    CAS  Google Scholar 

  94. O’Neill B, Williams AF, and Dubowski KM. Variability in blood alcohol concentration: implications for estimating individual results. J Stud Alcohol 44:222–230 (1983).

    PubMed  Google Scholar 

  95. Friel PN, Baer JS, and Logan BK. Variability of ethanol absorption and breath concentrations during a large scale alcohol administration study. Alcohol Clin Exp Res 19:1055–1060 (1995).

    CAS  PubMed  Google Scholar 

  96. Jones AW. Inter-individual variations in the disposition and metabolism of ethanol in healthy men. Alcohol 1:385–391 (1984).

    CAS  PubMed  Google Scholar 

  97. Hahn RG, Norberg A, and Jones AW. Over-shoot of ethanol in the blood after drinking on an empty stomach. Alc Alcohol 32:501–505 (1997).

    CAS  Google Scholar 

  98. Jones AW and Jönsson K-A. Between subject and within subject variations in the pharma-cokinetics of ethanol. Br J Clin Pharmacol 37:427–431 (1994).

    CAS  PubMed  Google Scholar 

  99. Passananti GT, Wolff CA, and Vesell ES. Reproducibility of individual rates of ethanol metabolism in fasting subjects. Clin Pharmacol Ther 47:389–396 (1990).

    CAS  PubMed  Google Scholar 

  100. Lotterle J, Husslein EM, Bolt J, and Wirtz PM. Tageszeitliche Unterschiede der Alkohol resorption. Blutalkohol 26:369–375 (1989).

    CAS  PubMed  Google Scholar 

  101. Dawson GW and Vestal RE. Smoking and drug metabolism. Pharmacol Ther 15:207–221 (1981).

    CAS  PubMed  Google Scholar 

  102. Johnson RD, Horowitz M, Maddox AF, Wishart JM, and Shearman DJC. Cigarette smoking and rate of gastric emptying—effect on alcohol absorption. Br Med J 302:20–23 (1991).

    CAS  Google Scholar 

  103. Scott AM, Kellow JE, Shuter B, Nolan JM, Hoschl R, and Jones MP. Effects of cigarette smoking on solid and liquid intragastric distribution and gastric emptying. Gastroenterology 104:410–416 (1993).

    CAS  PubMed  Google Scholar 

  104. Rose EF. Factors influencing gastric emptying. J Forensic Sci 24:200–206 (1979).

    CAS  PubMed  Google Scholar 

  105. Schvarcz E, Palmer M, Aman J, and Berne C. Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabet Care 18:674–676 (1993).

    Google Scholar 

  106. Bailey DN. Effect of coadministered drugs and ethanol on the binding of therapeutic drugs to human serum in-vitro. Therap Drug Monitor 23:71–74 (2001).

    CAS  Google Scholar 

  107. Edelman IS and Leibman J. Anatomy of body water and electrolytes. Am J Med 27:256–277 (1959).

    CAS  PubMed  Google Scholar 

  108. Lucey MR, Hill E, Young JP, Demo-Dananberg L, and Beresford TP. The influence of age and gender on blood ethanol concentrations in healthy humans. J Stud Alcohol 60: 103–110 (1999).

    CAS  PubMed  Google Scholar 

  109. Kwo PY, Ramchandani VA, O’Connor S, Amann D, Carr LG, Sandrasegaran K, et al. Gender differences in alcohol metabolism: relationship to liver volume and effect of adjustin2 for body mass. Gastroenterologv 115:1552–1557 (1998)

    CAS  Google Scholar 

  110. Mumenthaler MS, Taylor JL, and Yesavage JA. Ethanol pharmacokinetics in white women: nonlinear model fitting versus zero-order elimination analysis. Alcohol Clin Exp Res 24: 1353–1362 (2000)

    CAS  PubMed  Google Scholar 

  111. Mumenthaler MS, O’Hara R, Taylor JL, Friedman L, and Yesavage JA. Influence of menstrual cycle on flight simulator performance after alcohol ingestion. J Stud Alcohol 62: 422–433 (2001).

    CAS  PubMed  Google Scholar 

  112. Hobbes J, Boutagy J, and Shenfield GM. Interaction between ethanol and oral contraceptive steroids. Clin Pharmacol Ther 38:157–163 (1987).

    Google Scholar 

  113. Marshall AW, Kingstone D, Boss M, and Morgan MY. Ethanol elimination in males and females: relationship to menstrual cycle and body composition. Hepatology 5:701–706 (1983).

    Google Scholar 

  114. Winek CL and Carlagna M. Comparison of plasma, serum and whole blood ethanol concentrations. J Anal Toxicol 6:267–268 (1987).

    Google Scholar 

  115. Jones AW, Hahn RG, and Stalberg H. Distribution of ethanol and water between plasma and whole blood: inter- and intra-individual variations after administration of ethanol by intravenous infusion. Scand J Clin Lab Invest 50:775–780 (1990).

    CAS  PubMed  Google Scholar 

  116. Wang MQ, Nicholson ME, Jones CS, Fitzhugh EC, and Westerfield CR. Acute alcohol intoxication, body composition, and pharmacokinetics. Pharm Biochem Behav 43:641–643 (1992).

    CAS  Google Scholar 

  117. Jones AW and Neri A. (1985). Age-related changes in blood-alcohol parameters and subjective feelings of intoxication in healthy men. Alc Alcohol 20:45–52 (1985).

    CAS  Google Scholar 

  118. Vestal RE, McGuire EA, Tobin NA, Andrea R, Norris AH, and Mezey E. Aging and ethanol metabolism. Clin Pharmacol Ther 21:343–354 (1977).

    CAS  PubMed  Google Scholar 

  119. Endres HG and Gruner O. Comparison of D20 and ethanol dilutions in total body water measurements in humans. Clin Investig 72:830–837 (1994).

    CAS  PubMed  Google Scholar 

  120. Jones AW, Hahn RG, and Stalberg HP. Pharmacokinetics of ethanol in plasma and whole blood: estimation of total body water by the dilution principle. Eur J Clin Pharmacol 42: 445–448 (1992).

    CAS  PubMed  Google Scholar 

  121. Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site; implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics. Clin Pharmacokinet 17:175–199 (1989)

    CAS  PubMed  Google Scholar 

  122. Mather LE. Anatomical-physiological approaches in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 40:707–722 (2001).

    CAS  PubMed  Google Scholar 

  123. Jones AW, Norberg A, and Hahn RG. Concentration-time profiles of ethanol in arterial and venous blood and end-expired breath during and after intravenous infusion. J Forensic Sci 42:1088–1094 (1997).

    CAS  PubMed  Google Scholar 

  124. Meibohm B, Beierle I, and Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 21:329–342 (2002).

    Google Scholar 

  125. Cheymol G. Effects of obesity on pharmacokinetics: implications for drug therapy. Clin Pharmacokinet 39:215–231 (2000).

    CAS  PubMed  Google Scholar 

  126. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 25:502–507 (2001).

    CAS  PubMed  Google Scholar 

  127. Wartburg Von J-P. Pharmacokinetics of alcohol. In: Batt RC and Crow KE, eds. Human metabolism of alcohol, Vol. 1: pharmacokinetics, medicolegal and general interests. Boca Raton, FL: CRC Press, 1989:9–22.

    Google Scholar 

  128. Droenmer P, Schmitt G, Aderjan R, and Zimmer H. A kinetic model describing the pharmacokinetics of ethyl glucuronide in humans. Forens Sci Intern 126:24–29 (2002).

    Google Scholar 

  129. Seidl S, Wurst FM, and Alt A. Ethyl glucuronide: a biological marker for recent alcohol consumption. Addict Biol 6:205–212 (2001).

    CAS  PubMed  Google Scholar 

  130. Jones AW. Excretion of alcohol in urine and diuresis in healthy men in relation to their age, the dose administered and the time after drinking. Forens Sci Intern 45:217–224 (1990).

    CAS  Google Scholar 

  131. Matsumoto H and Fujui Y. Pharmacokinetics of ethanol a review of the methodology. Addict Biol 7:5–14 (2002).

    CAS  PubMed  Google Scholar 

  132. Ehring T, Bosron WJ, and Li T-K. Alcohol and aldehyde dehydrogenase. Alc Alcohol 25: 105–116 (1990).

    Google Scholar 

  133. Jörnvall H, Hoog J-O, Persson B, and Pares X. Pharmacogenetics of the alcohol dehydrogenase system. Pharmacology 61:184–191 (2000).

    PubMed  Google Scholar 

  134. Pettersson G. Liver alcohol dehydrogenase. CRC Critical Rev Biochem 21:349–389 (1987).

    CAS  Google Scholar 

  135. Jörnvall H and Hoog JO. Nomenclature of alcohol dehydrogenase. Alc. Alcohol 30:153–161 (1995).

    Google Scholar 

  136. Holford NGH. Clinical pharmacokinetics of ethanol. Clin Pharmacokinet 13:273–292 (1987).

    CAS  PubMed  Google Scholar 

  137. Wedel M, Pieters JE, Pikaar NA, and Ockhuizen T. Application of a three-compartment model to a study of the effects of sex, alcohol dose and concentration, exercise and food consumption on the pharmacokinetics of ethanol in healthy volunteers. Alc Alcohol 26: 329–336 (1991).

    CAS  Google Scholar 

  138. Norberg A, Jones AW, Hahn RG, and Gabrielsson J. Role of variability in explaining ethanol nharmacokinetics. Clin Pharmacokinet 42:1–31 (2003).

    CAS  PubMed  Google Scholar 

  139. Lundquist F and Wolthers H. The kinetics of alcohol elimination in man. Acta Pharmacol Toxicol 14:265–289 (1958).

    CAS  Google Scholar 

  140. Wilkinson PK, Sedman AJ, Sakmar E, Kay DR, and Wagner JG. Pharmacokinetics of ethanol after oral administration in the fasting state. J Pharmacokinet Biopharm 5:207–224 (1977).

    CAS  PubMed  Google Scholar 

  141. Wagner JG, Wilkinson PK, and Games DA. Parameters of Vmax and km for elimination of alcohol in young male subjects following low doses of alcohol. Alc Alcohol 24:555–564 (1989).

    CAS  Google Scholar 

  142. Wilkinson PK. Pharmacokinetics of ethanol—a review. Alcohol Clin Exp Res 4:6–21 (1980)

    CAS  PubMed  Google Scholar 

  143. Wagner JG. Lack of first-pass metabolism of ethanol at blood concentrations in the social drinking range. Life Sci 39:407–414 (1986).

    CAS  PubMed  Google Scholar 

  144. Jacobsen D and McMartin KE. Methanol and ethylene glycol poisonings mechanism of toxicity clinical course diagnosis and treatment. Med Toxicol 1:309–334 (1986).

    CAS  PubMed  Google Scholar 

  145. Eder AF, McGrath CM, Dowdy YG, Tomaszewski JE, Rosenberg FM, et al. Ethylene glycol poisoning: toxicokinetics and analytical factors affecting laboratory diagnosis. Clin Chem 44:168–177 (1998).

    CAS  PubMed  Google Scholar 

  146. Karlson-Stibler C and Persson H. Ethylene glycol poisoning: experiences from an epidemic in Sweden. J Toxicol Clin Tox 30:565–574 (1992).

    Google Scholar 

  147. Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, and Peacock EA. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med 344:87–94 (2002).

    Google Scholar 

  148. Nicholson KL and Balster RL. GHB: a new and novel drug of abuse. Drug Alc Dep 63:1–22 (2001).

    CAS  Google Scholar 

  149. Roe O. The metabolism and toxicity of methanol. Pharmacol Rev 7:399–412 (1955).

    CAS  PubMed  Google Scholar 

  150. Mani JC, Pietruszko R, and Theorell H. Methanol activity of alcohol dehydrogenase from human liver, horse liver and yeast. Arch Biochem Biophys 140:52–59 (1970).

    CAS  PubMed  Google Scholar 

  151. Fraser AD. Clinical toxicologic implications of ethylene glycol and glycolic acid poisoning. Therap Drug Monitor 24:232–238 (2002).

    CAS  Google Scholar 

  152. Jacobsen D and McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Tox 35:127–143 (1997).

    CAS  Google Scholar 

  153. Burkhart K. Methanol and ethylene glycol toxicity. J Toxicol Clin Tox 35:149–150 (1997).

    CAS  Google Scholar 

  154. Barceloux DG, Krenzelok EP, Olson K, and Watson WW. American academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. J Toxicol Clin Tox 37:537–560 (1999).

    CAS  Google Scholar 

  155. Wiener HL and Richardson KE. The metabolism and toxicity of ethylene glycol. Res Commun Sub Abuse 9:77–87 (1988).

    CAS  Google Scholar 

  156. Majchrowicz E and Mendelson JH. Blood methanol concentrations during experimental induced ethanol intoxications in alcoholics. J Pharmacol EXp Ther 179:293–300 (1971).

    CAS  PubMed  Google Scholar 

  157. Jones AW, Skaggerberg S, Yonekura A, and Sato A. Metabolic interaction between endogenous methanol and exogenous ethanol studied in human volunteers by analysis of breath. Pharmacol Toxicol 65:48–53 (1990).

    Google Scholar 

  158. Haffner H-T, Banger M, Graw M, Besserer K, and Brink T. The kinetics of methanol elimination in alcoholics and the influence of ethanol. Forens Sci Intern 89:129–136 (1997).

    CAS  Google Scholar 

  159. Jones AW and Sternebring B. Kinetics of ethanol and methanol in alcoholics during detoxication. Alc Alcohol 27:641–647 (1992).

    CAS  Google Scholar 

  160. Graw M, Haffner H-T, Althaus L, Besserer K, and Voges S. Invasion and distribution of ethanol. Arch Toxicol 74:313–321 (2000).

    CAS  PubMed  Google Scholar 

  161. Haffner H-T, Besserer K, Graw M, and Voges S. Methanol elimination in non-alcoholics. Inter- and intra-individual variation. Forens Sci Intern 86:69–76 (1997).

    CAS  Google Scholar 

  162. Jones AW. Elimination half-life of methanol during hangover. Pharmacol Toxicol 60:217–220 (1987).

    CAS  PubMed  Google Scholar 

  163. Blomstrand R, Ostling-Wintzell H, Lof A, McMartin K, Tolf BR, and Hedstrom KG. Pyrazoles as inhibitors of alcohol oxidation and as important tools in alcohol research: an approach to therapy against methanol poisoning. Proc Natl Acad Sci USA 76:3499–503 (1979).

    CAS  PubMed  Google Scholar 

  164. Baud FJ, Galliot M, Astier A, Vubien D, Gamier R, Likforman J, et al. Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. N Engl J Med 319:97–100 (1988).

    CAS  PubMed  Google Scholar 

  165. Jobard E, Harry P, Turcant A, Roy PM, and Alain P. 4-methylpyrazole and hemodialysis in ethylene glycol poisoning. J Toxicol Clin Tox 34:373–377 (1996)

    CAS  Google Scholar 

  166. Bekka R, Borron SW, Astier A, Sandouk P, Bismuth C, and Baud FJ. Treatment of methanol and isopropanol poisoning with intravenous fomepizole. J Toxicol Clin Tox 39:59–67 (2001).

    CAS  Google Scholar 

  167. Brent J, McMartin K, Phillips S, Aaron C, and Kulig K. Fomepizole for the treatment of methanol poisoning. N Engl J Med 344:424–429 (2001).

    CAS  PubMed  Google Scholar 

  168. Sarkola T and Eriksson CJP. Effect of 4-methyl pyrazole on endogenous plasma ethanol and methanol levels in humans. Alcohol Clin Exp Res 25:513–516 (2001).

    CAS  PubMed  Google Scholar 

  169. Kaplan HL, Forney RB, Hughes FW, and Jain NC. Chloral hydrate and alcohol metabolism in human subjects. J Forensic Sci 12:295–304 (1967).

    CAS  PubMed  Google Scholar 

  170. Sellers EM, Lang M, Koch-Weser J, LeBlanc E, and Kalant H. Interaction of chloral hydrate and ethanol in man. 1. Metabolism. Clin Pharmacol Ther 13:37–49 (1972)

    CAS  Google Scholar 

  171. Heller PF, Goldberger BA, and Caplan YH. Chloral hydrate overdose: trichloroethanol detection by gas chromatography-mass spectrometry. Forens Sci Intern 52:231–234 (1992).

    CAS  Google Scholar 

  172. Hawkins RD and Kalant H. The metabolism of ethanol and its metabolic effects. Pharmacol Rev 24:67–157 (1972).

    CAS  PubMed  Google Scholar 

  173. Wartburg von JP and Bühler R. Biology of disease—alcoholism and aldehydism: new biomedical concepts. Lab Invest 50:5–15 (1984).

    Google Scholar 

  174. Crabbe DW, Edenberg HJ, Bosron WH, and Li T-K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. J Clin Invest 83;314–316 (1989).

    Google Scholar 

  175. Eriksson CJP. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 25:15S-32S (2001).

    CAS  PubMed  Google Scholar 

  176. Mizoi Y, Tatsuno T, Adachi J, Kogame M, Fukunaga T, Fujiwara S, et al. Alcohol sensitivity related to polymorphism of alcohol metabolizing enzymes in Japanese. Pharm Biochem Behav 18(Suppl 1):127–133 (1983).

    Google Scholar 

  177. Harada S, Agarwal DP, Normura F, and Higuchi S. Metabolic and ethnic determinants of alcohol drinking habits and vulnerability to alcohol-related disorders. Alcohol Clin Exp Res 25:71S-75S (2001).

    CAS  PubMed  Google Scholar 

  178. Harada S, Agarwal DP, and Goedde HW. Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 2:982 (1981).

    CAS  PubMed  Google Scholar 

  179. Bosron WF and Li T-K. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology 6: 502–510 (1986).

    CAS  PubMed  Google Scholar 

  180. Goedde HW, Agarwal DP, and Harada S. Pharmacogenetics of alcohol sensitivity. Pharma-col Biochem Behav 18(Suppl 1):161–166 (1983).

    CAS  Google Scholar 

  181. Peachey JE and Sellers EM. The disulfiram and calcium carbimide acetaldehyde mediated ethanol reaction. Pharmacol Ther 15:89–97 (1981).

    CAS  PubMed  Google Scholar 

  182. McBride WJ, Li T-K, Deitrich RA, Zimatkin S, Smith BR, and Rodd-Henricks ZA. Involvement of acetaldehyde in alcohol addiction. Alcohol Clin Exp Res 26:114–119 (2002).

    PubMed  Google Scholar 

  183. Lindros KO. Human blood acetaldehyde levels. With improved methods a clearer picture emerges. Alcohol Clin Exp Res 7:70–75 (1983).

    CAS  PubMed  Google Scholar 

  184. Hald J and Jacobsen E. A drug sensitizing the organism to ethyl alcohol. Lancet 2:1001–1004 (1948).

    CAS  PubMed  Google Scholar 

  185. Yoshida A. Genetic polymorphisms of alcohol metabolizing enzymes related to alcohol sensitivity and alcoholic disease. Alc Alcohol 29:693–696 (1994).

    CAS  Google Scholar 

  186. Park CW and Riggio S. Disulfiram-ethanol induced delirium. Ann Pharmacother 35:32–35 (2001).

    CAS  PubMed  Google Scholar 

  187. Jones AW, Neiman J, and Hillbom M. Concentration-time profiles of ethanol and acetaldehyde in human volunteers treated with the alcohol-sensitizing drug, calcium carbimide. Br J Clin Pharmacol 25:213–221 (1988).

    CAS  PubMed  Google Scholar 

  188. Jones AW. Drug-alcohol flush reaction and breath-acetaldehyde concentration: no interference with an infrared breath-alcohol analyzer. J Anal Toxicol 10:98–101 (1986).

    CAS  PubMed  Google Scholar 

  189. Lindros KO, Stowell A, Pikkarainen P, and Salaspuro M. The disulfiram (antabus) alcohol reaction in male alcoholics: its efficient management by 4-methyl pyrazole. Alcohol Clin Exp Res 5:528–530 (1981).

    CAS  PubMed  Google Scholar 

  190. Heath MJ, Pachar JV, Perez-Martinez AL, and Toseland PA. An exceptional case of lethal disulfiram alcohol reaction. Forens Sci Int 56:45–50 (1992).

    CAS  Google Scholar 

  191. Yamamoto H, Tangegashima A, Hosoe H, and Fukunaga T. Fatal acute alcohol intoxication in an ALDH2 heterozygote: a case report. Forens Sci Intern 112:201–207 (2000).

    CAS  Google Scholar 

  192. Jerntorp P. The chlorpropamide alcohol flush test in diabetes mellitus: methods for objective evaluation. Scand J Clin Lab Invest 43:249–254 (1984).

    Google Scholar 

  193. Groop L, Eriksson CJP, Boll-WAhlin E, and Melander A. Chlorpropamide-alcohol flush: significance of body weight, sex, and serum chlorpropamide level. Eur J Clin Pharmacol 26:723–725 (1984).

    CAS  PubMed  Google Scholar 

  194. Jerntorp P, Ohlin H, Sundkvist G, and Almer LO. Effects of chlorpropamide and alcohol on aldehyde dehydrogenase activity and blood acetaldehyde concentration. Diabetes Res 3:369–372 (1986).

    CAS  PubMed  Google Scholar 

  195. Chen Z, Zhang J, and Stamler JS. Identification of the enzymatic mechanism of nitroglycerine bioactivation. Proc Natl Acad Sci USA 99:8306–8311 (2002).

    CAS  PubMed  Google Scholar 

  196. Williams CS and Woodcock KR. Do ethanol and metronidazole interact to produce a disulfiram-like reaction? Ann Pharmacother 34:255–257 (2000).

    CAS  PubMed  Google Scholar 

  197. Cina SJ, Russell RA, and Conradi SE. Sudden death due to metronidazole-ethanol interaction. Am J Forens Med Pathol 17:343–346 (1996).

    CAS  Google Scholar 

  198. Visapää J-P, Tillonen JS, Kalhovaara PS, and Salaspuro MP. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother 36:971–974 (2002).

    PubMed  Google Scholar 

  199. Lieber CS. Cytochrome P4502E1: its physiological and pathological role. Physiol Rev 77: 517–544 (1997).

    CAS  PubMed  Google Scholar 

  200. Lieber CS. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1958–1998) —a review. Alcohol Clin Exp Res 23:991–1007 (1999).

    CAS  PubMed  Google Scholar 

  201. Spatzenegger M and Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev 27:397–417 (1995).

    CAS  PubMed  Google Scholar 

  202. Bertilsson L, Dahl M-L, Dalen P, and Al-Shurbaji A. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 53:111–122 (2001).

    Google Scholar 

  203. Cho AK, Narimatsu S, and Kumagai Y. Metabolism of drugs of abuse by cytochromes P450. Addict Biol 4:283–301 (1999).

    CAS  PubMed  Google Scholar 

  204. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 40:243–288 (1989).

    Google Scholar 

  205. Teschke R and Gellert J. Hepatic microsomal ethanol-oxidizing system (MEOS): metabolic aspects and clinical implications. Alcohol Clin Exp Res 10:20S-32S (1986).

    CAS  PubMed  Google Scholar 

  206. Guengerich EP. Cytochrome P450 enzymes. Am Sci 81:440–447 (1993).

    Google Scholar 

  207. Landrum-Michalets E. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotheranv 18:84–112 (1998).

    Google Scholar 

  208. Barry M and Feely J. Enzyme induction and inhibition. Pharmacol Ther 48:71–94 (1990).

    PubMed  Google Scholar 

  209. Lin JH and Lu AYH. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–390 (1998).

    CAS  PubMed  Google Scholar 

  210. Lin JH and Lu AYH. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Ann Rev Pharmacol 41:535–567 (2001).

    CAS  Google Scholar 

  211. Murray M and Reidy GF. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol Rev 42:85–101 (1990).

    CAS  PubMed  Google Scholar 

  212. Park BK, Pirmohamed M, and Kitteringham NR. The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacol Ther 58:385–424 (1995).

    Google Scholar 

  213. Park BK, Kitteringham NR, Pirmohamed M, and Tucker GT. Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. Br J Clin Pharmacol 41:477–491 (1996).

    CAS  PubMed  Google Scholar 

  214. Park DV, Ioannides C, and Lewis DFV. The role of the cytochrome P450 in the detoxication and activation of drugs and other chemicals. Can J Physiol Pharmacol 69:537–549 (1991).

    Google Scholar 

  215. Oneta CM, Lieber AS, Li J, Rüttimann S, Schmid B, Lattmann J, et al. Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47–52 (2002).

    CAS  PubMed  Google Scholar 

  216. Pelkonen O and Sotaniemi E. Drug metabolism in alcoholics. Pharmacol Ther 16:261–268 (1982).

    CAS  PubMed  Google Scholar 

  217. Keiding S, Christensen NJ, Damgaard SE, Dejgård A, Iversen HL, Jacobsen A, et al. Ethanol metabolism in heavy drinkers after massive and moderate alcohol intake. Biochem Pharmacol 32:3097–3102 (1983).

    CAS  PubMed  Google Scholar 

  218. Morgon DJ and McLean AJ. Clinical pharmacokinetics and pharmacodynamic considerations in patients with liver disease: an update. Clin Pharmacokinet 29:370–391 (1995).

    Google Scholar 

  219. Tanaka E, Terada M, and Misawa S. Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Therap 25:165–175 (2000).

    CAS  Google Scholar 

  220. Klotz U and Ammon E. Clinical and toxicological consequences of the inductive potential of ethanol. Eur J Clin Pharmacol 54:7–12 (1998).

    CAS  PubMed  Google Scholar 

  221. Nakajima T. Cytochrome P450 isoforms and the metabolism of volatile hydrocarbons of low relative molecular mass. J Occup Health 99:83–91 (1997).

    Google Scholar 

  222. Salmela KS, Kessova IG, Tsyrlov IB, and Lieber CS. Respective roles of human cytochrome P4502E1 1A2 and 3A4 in the hepatic microsomal oxidizing system. Alcohol Clin Exp Res 22:2125–2132 (1998).

    CAS  PubMed  Google Scholar 

  223. Slattery JT, Nelson SD, and Thummel KE. The complex interaction between ethanol and acetaminophen. Clin Pharmacol Ther 60:241–246 (1996).

    CAS  PubMed  Google Scholar 

  224. Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 49:291–301 (2000).

    CAS  PubMed  Google Scholar 

  225. Makin AJ and Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med 42:3433–3483 (1997).

    Google Scholar 

  226. Schmidt LE and Dalhoff K. Concomitant overdosing of other drugs in patients with paracetamol poisoning. Br J Clin Pharmacol 53:535–541 (2002).

    CAS  PubMed  Google Scholar 

  227. Riordan SM and Williams R. Alcohol exposure and paracetamol-induced hepatotoxicity. Addict Biol 7:191–206 (2002).

    CAS  PubMed  Google Scholar 

  228. Thomas SHL. Paracetamol (acetaminophen) poisoning. Pharmacol Ther 60:91–120 (1993).

    CAS  PubMed  Google Scholar 

  229. Vale JA and Proundfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 346:547–552 (1995).

    CAS  PubMed  Google Scholar 

  230. Zimmerman HJ and Maddrey WC. Acetaminophene (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 22: 767–773 (1995).

    CAS  PubMed  Google Scholar 

  231. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, and Benjamin SB. Acetaminophene hepatotoxicity in alcoholics. Ann Intern Med 104:399–404 (1986).

    CAS  PubMed  Google Scholar 

  232. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. Clin Toxicol 40:3–20(2002).

    Google Scholar 

  233. Makin AJ, Wendon J, and Williams R. A 7-year experience of severe acetaminopheneinduced hepatotoxicity (1987–1993). Gastroenterology 109:1907–1916 (1995).

    CAS  PubMed  Google Scholar 

  234. Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophene poisoning: a critical review. J Toxicol Clin Toxicol 36:277–285 (1998).

    CAS  PubMed  Google Scholar 

  235. Whitcomb DC and Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272:1845–1850 (1994).

    CAS  PubMed  Google Scholar 

  236. Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE, and Watkins PB. Ethanol and production of the hepatoxic metabolite of acetaminophene in healthy adults. Clin Pharmacol Ther 67:591–599 (2000).

    CAS  PubMed  Google Scholar 

  237. Janes J and Routledge PA. Recent developments in the management of paracetamol (acetaminophene) poisoning. Drug Safety 7:170–177 (1992).

    CAS  PubMed  Google Scholar 

  238. Jones AL. Recent advances in the management of poisoning. Therap Drug Monitor 24: 150–155 (2002).

    CAS  Google Scholar 

  239. Pond SM and Tozer TN. First-pass elimination; basic concepts and clinical consequences. Clin Pharmacokinet 9:1–25 (1984).

    CAS  PubMed  Google Scholar 

  240. Lin JH, Chiba M, and Baillie TA. Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol Rev 51:135–157 (1999).

    CAS  PubMed  Google Scholar 

  241. Baraona E, Gentry RT, and Lieber CS. Bioavailability of alcohol: role of gastric metabolism and its interaction with other drugs. Dig Dis 12:351–367 (1994).

    CAS  PubMed  Google Scholar 

  242. Julkunen RJK, Dipadova C, and Lieber CS. First pass metabolism of ethanol-a gastrointestinal barrier against the systemic toxicity of ethanol. Life Sci 37:567–573 (1985).

    CAS  PubMed  Google Scholar 

  243. Frezza M, Dipadova C, Pozzato G, Terpin M, Baraona E, and Lieber CS. High blood alcohol levels in women—the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:95–99 (1990).

    CAS  PubMed  Google Scholar 

  244. DiPadova C, Roine R, Frezza M, Gentry RT, Baraona E, and Lieber CS. Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists. JAMA 267:83–86 (1992).

    CAS  PubMed  Google Scholar 

  245. Hempel JD and Pietruszko R. Human stomach alcohol dehydrogenase: isoenzyme composition and catalytic properties. Alcohol Clin Exp Res 3:95–98 (1979).

    CAS  PubMed  Google Scholar 

  246. Gentry RT, Baraona E, and Lieber CS. Gastric first pass metabolism of alcohol. J Lab Clin Med 123:21–26 (1994).

    CAS  PubMed  Google Scholar 

  247. Lieber CS, Gentry RT, and Barana E. First pass metabolism of ethanol. Alc Alcohol Suppl 2:163–169 (1994).

    CAS  Google Scholar 

  248. Caballeria J, Frezza M, Hernandez-Munoz R, Dipadova C, Korsten MA, Baraona E, and Lieber CS. Gastric origin of the first-pass metabolism of ethanol in humans: effect of gastrectomy. Gastroenterology 97:1205–1209 (1989).

    CAS  PubMed  Google Scholar 

  249. Roine R, Gentry RT, Hernandez-Munoz R, Baraona E, and Lieber CS. Aspirin increases blood alcohol concentrations in humans after ingestion of ethanol. JAMA 264:2406–2408 (1990).

    CAS  PubMed  Google Scholar 

  250. DiPadova C, Worner TM, Julkunen RJK, and Lieber CS. Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology 92:1169–1173 (1987).

    CAS  PubMed  Google Scholar 

  251. Julkunen RJK, Tannenbaum L, Baraona E, and Lieber CS. First-pass metabolism of ethanol: an important determinant of blood levels after alcohol consumption. Alcohol 2:437–441 (1985).

    CAS  PubMed  Google Scholar 

  252. Lim RT, Gentry RT, Ito D, Yokoyarna H, Baraona E, and Lieber CS. First-pass metabolism of ethanol is predominantly gastric. Alcohol Clin EXp Res 17:1337–1344 (1993).

    CAS  PubMed  Google Scholar 

  253. Lieber CS. Gastritis in the alcoholic, relationship to gastric alcohol metabolism and helicobacter pylori. Add Biol 3:423–434 (1998).

    Google Scholar 

  254. Levitt MD. Do histamine-2 receptor antagonists influence the metabolism of ethanol. Ann Intern Med 118:564–565 (1993).

    CAS  PubMed  Google Scholar 

  255. Levitt MD. The case against first-pass metabolism of ethanol in the stomach. J Lab Clin Med 123:28–31 (1994).

    CAS  PubMed  Google Scholar 

  256. Levitt MD and Levitt DG. The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol. J Pharmacol Exp Ther 269:297–304 (1994).

    CAS  PubMed  Google Scholar 

  257. Levitt MD and Levitt DG. Appropriate use and misuse of blood concentration measurements to quantitate first-pass metabolism. J Lab Clin Med 136:275–280 (2000)

    CAS  PubMed  Google Scholar 

  258. Gupta AM, Baraona E, and Lieber CS. Significant increase of blood alcohol by cimetidine after repetitive drinking of small alcohol doses. Alcohol Clin Exp Res 19:1083–1087 (1995).

    CAS  PubMed  Google Scholar 

  259. Arora S, Baraona E, and Lieber CS. Alcohol levels are increased in social drinkers receiving ranitidine. Am J Gastroenterol 95:208–213 (2000).

    CAS  PubMed  Google Scholar 

  260. Oneta CM, Simanowski UA, Martinez M, Allali-Hassani A, Pares X, Homann N, et al. First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut 43:612–619 (1998).

    CAS  PubMed  Google Scholar 

  261. Horowitz M, Maddox A, Bochner M, Wishart J, Bratasuik K, Collins P, et al. Relationship between gastric emptying of solid and caloric liquid meals and alcohol absorption. Am J Physiol 257:G291-G298 (1989).

    CAS  PubMed  Google Scholar 

  262. Mattila MJ and Venho VMK. Drug absorption from abnormal gastrointestinal tract. Prog Pharmacol 2:63–86 (1979).

    Google Scholar 

  263. Petring OU and Flachs H. Intersubject and intrasubject variability of gastric emptying in healthy volunteers measured by scintigraphy and paracetamol absorption. Br J Clin Pharmacol 29:703–708 (1990).

    CAS  PubMed  Google Scholar 

  264. Lartigue S, Bizais Y, Desvarannes SB, Murat A, Pouliquen B, and Galmiche JP. Inter- and intrasubject variability of solid and liquid gastric emptying parameters—a scintigraphic study in healthy subjects and diabetic patients. Dig Dis Sci 39:109–115 (1994).

    CAS  PubMed  Google Scholar 

  265. Elashoff JD, Reedy TJ, and Meyer JH. Analysis of gastric emptying data. Gastroenterology 83:1306–1312 (1982).

    CAS  PubMed  Google Scholar 

  266. Madsen JL. Effects of gender, age, and body mass index on gastrointestinal transit times. Dig Dis Sci 37:1548–1553 (1992).

    CAS  PubMed  Google Scholar 

  267. Goo RH, Moore JG, Greenberg E, and Alazraki NP. Circadian variations in gastric emptying of meals in humans. Gastroenterology 93:515–518 (1987).

    CAS  PubMed  Google Scholar 

  268. Hunt JN and Stubbs DF. The volume and energy content of meals as determinants of gastric emptying. J Physiol 245:209–225 (1975).

    CAS  PubMed  Google Scholar 

  269. Ammon E, Schafer C, Hoffmann U, and Klotz U. Disposition and first pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender? Clin Pharmacol Ther 59:503–513 (1996).

    CAS  PubMed  Google Scholar 

  270. Rinetti M, Ugolotti G, Calbiani B, Colombi-Zinelli L, Cisternino M, and Papa N. Antiinflammatory drugs and gastric emptying. A comparison between acetylsalicylic acid and carprofen. Arzneimittelforschung 32:1561–1563 (1982).

    CAS  PubMed  Google Scholar 

  271. Pfeiffer A, Hogl B, and Kaess H. Effect of ethanol and commonly ingested alcoholic beverages on gastric emptying and gastrointestinal transit. Clin Investig 70:487–491 (1992).

    CAS  PubMed  Google Scholar 

  272. Mascord D, Smith J, Starmer G, and Whitfield J. Effect of increasing the alcohol metabolism rate on plasma acetate concentration. Alc Alcohol 27:25–28 (1992).

    CAS  Google Scholar 

  273. O’Conner S, Morzorati S, Christian J, and Li K. Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 22:202–210 (1998).

    Google Scholar 

  274. Svensson CK, Edwards DJ, Mauriello PM, Barde SH, Foster AC, Lanc RA, et al. Effect of food on hepatic blood flow. Implications in the “food effect” phenomenon. Clin Pharmacol Ther 34:316–323 (1983).

    CAS  PubMed  Google Scholar 

  275. Palmer RH, Frank WO, Nambi P, Wetherington JD, and Fox MJ. Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. Am J Gastroenterol 86:1749–1755 (1991).

    CAS  PubMed  Google Scholar 

  276. Melander O, Liden A, and Melander A. Pharmacokinetic interactions of alcohol and acetylsalicylic acid. Eur J Clin Pharmacol 48:151–153 (1995).

    CAS  PubMed  Google Scholar 

  277. Gentry RT, Baraona E, Amir I, Roine R, Chayes ZW, Sharma R, and Lieber CS. Mechanism of the aspirin-induced rise in blood alcohol levels. Life Sci 65:2505–2512 (1999).

    CAS  PubMed  Google Scholar 

  278. Kechagias S, Jönsson K-A, Norlander B, Carlsson B, and Jones AW. Low-dose aspirin decreases blood alcohol concentrations by delaying gastric emptying. Eur J Clin Pharmacol 53:241–246 (1997).

    CAS  PubMed  Google Scholar 

  279. Barron SE, Perry JR, and Ferslew KE. The effect of ibuprofen on ethanol concentration and elimination rate. J Forensic Sci 37:432–435 (1992).

    CAS  PubMed  Google Scholar 

  280. Minocha A, Barth JT, Herold DA, Gideon DA, and Spyker DA. Modulation of ethanolinduced central nervous system depression by ibuprofen. Clin Pharmacol Ther 39:123–127 (1986).

    CAS  PubMed  Google Scholar 

  281. Greiff JMC and Rowbotham D. Pharmacokinetic drug interactions with gastrointestinal motility modifying agents. Clin Pharmacokinet 27:447–461 (1994).

    CAS  PubMed  Google Scholar 

  282. Griffiths GH, Owen GM, Camphell H, and Shields R. Gastric emptying in health and in gastroduodenal disease. Gastroenterology 54:1–7 (1968).

    Google Scholar 

  283. Madsen JL. Effects of cisapride on gastrointestinal transit in healthy humans. Dig Dis Sci 35:1500–1504 (1990).

    CAS  PubMed  Google Scholar 

  284. McCallum RW, Prakash C, Campoli-Richards DM, and Goa KL. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 36:652–681 (1988).

    CAS  PubMed  Google Scholar 

  285. Dziekan G, Contesse J, Werth B, Schwarzer G, and Reinhart WH. Cisapride increases peak plasma and saliva ethanol levels under fasting conditions. J Intern Med 242:479–482 (1997).

    CAS  PubMed  Google Scholar 

  286. Kechagias S, Jönsson KA, and Jones AW. Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride. Br J Clin Pharmacol 48:728–732 (1999).

    CAS  PubMed  Google Scholar 

  287. Deponti F, Giaroni C, Cosentino M, Lecchini S, and Frigo G. Calcium-channel blockers and gastrointestinal motility—basic and clinical aspects. Pharmacol Ther 60:121–148 (1993).

    CAS  Google Scholar 

  288. Bauer LA, Schumock G, Horn J, and Opheim K. Verapamil inhibits ethanol elimination and prolongs the perception of intoxication. Clin Pharmacol Ther 52:6–10 (1992).

    CAS  PubMed  Google Scholar 

  289. Perez-Reyes M, White WR, and Hicks RE. Interaction between ethanol and calcium channel blockers in humans. Alcohol Clin Exp Res 16:769–775 (1992).

    CAS  PubMed  Google Scholar 

  290. Edelbroek MAL, Horowitz M, Wishart JM, and Akkermans LMA. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med 34:582–588 (1993).

    CAS  PubMed  Google Scholar 

  291. Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, and Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol 257:G470–G474 (1989).

    CAS  PubMed  Google Scholar 

  292. Urbain JL, Vantrappen G, Janssens J, Van Cutsem E, Peeters T, and De Roo M. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med 31:1490–1493 (1990).

    CAS  PubMed  Google Scholar 

  293. Smith SR and Kendall MJ. Ranitidine and cimetidine: a comparison of their potential to cause clinically important drug interactions. Clin Pharmacokinet 15:44–56 (1988).

    CAS  PubMed  Google Scholar 

  294. Amir I, Anwar N, Baraona E, and Lieber CS. Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying. Life Sci 58:511–518 (1996).

    CAS  PubMed  Google Scholar 

  295. Bye A, Lacey LF, Gupta S, and Powell JR. Effect of ranitidine hydrochloride (150 mg twice daily) on the pharmacokinetics of increasing doses of ethanol (0.15, 0.3, 0.6 g kg-1). Br J Clin Pharmacol 41:129–133 (1996).

    CAS  PubMed  Google Scholar 

  296. Toon S, Khan AZ, Holt BI, Mullins FG, Langley SJ, and Rowland MM. Absence of effect of ranitidine on blood alcohol concentrations when taken morning, midday, or evening with or without food. Clin Pharmacol Ther 55:385–391 (1994).

    CAS  PubMed  Google Scholar 

  297. Raufman JP, Notarfrancesco V, Raffaniello RD, and Straus EW. Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, non-alcoholic men. Ann Intern Med 118: 488–494 (1993).

    CAS  PubMed  Google Scholar 

  298. Tanaka E and Nakamura K. Effects of H-2 receptor antagonists on ethanol metabolism in Japanese volunteers. Br J Clin Pharmacol 26:96–99 (1988).

    CAS  PubMed  Google Scholar 

  299. Somogyi A and Muirhead M. Pharmacokinetic interactions of cimetidine. Clin Pharmacokinet 12:321–366 (1987).

    CAS  PubMed  Google Scholar 

  300. Hernandez-Munoz R, Caballeria J, Baraona E, Uppal R, Greenstein R, and Lieber CS. Human gastric alcohol dehydrogenase—its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcohol Clin Exp Res 14:946–950 (1990).

    CAS  PubMed  Google Scholar 

  301. Caballeria J, Baraona E, Rodamilans M, and Lieber CS. Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels. Gastroenterology 96:388–392 (1989).

    CAS  PubMed  Google Scholar 

  302. Stone CL, Hurley TD, Peggs CF, Kedishvili NY, Davis GJ, Thomasson HR, et al. Cimetidine inhibition of human gastric and liver alcohol dehydrogenase isoenzymes: identification of inhibitor complexes by kinetics and molecular modeling. Biochemistry 34: 4008–4014 (1995).

    CAS  PubMed  Google Scholar 

  303. Dauncey H, Chesher GB, and Palmer RH. Cimetidine and ranitidine: lack of effect on the pharmacokinetics of an acute ethanol dose. J Clin Gastroenterol 17:189–194 (1993).

    CAS  PubMed  Google Scholar 

  304. Fraser AG, Hudson M, Sawyerr AM, Smith M, Rosalki SB, and Pounder RE. Ranitidine, cimetidine, famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal. Aliment Pharmacol Therapeut 6:693–700 (1992).

    CAS  Google Scholar 

  305. Fraser AG, Prewett EJ, Hudson M, Sawyerr AM, Rosalki SB, and Pounder RE. The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Therapeut 5:263–272 (1991).

    CAS  Google Scholar 

  306. Clemmesen JO, Ott P, and Sestoft L. The effect of cimetidine on ethanol concentrations in fasting women and men after two different doses of alcohol. Scand J Gasterenterol 32:217–220 (1997).

    CAS  Google Scholar 

  307. Casini A, Pizzigallo AM, Mari F, Bertol E, and Surrenti C. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) dose not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer. Am J Gastroenterol 89: 745–749 (1994).

    CAS  PubMed  Google Scholar 

  308. Sharma R, Gentry RT, Lim RT, and Lieber CS. First-pass metabolism of ethanol: absence of diurnal variation and its inhibition by cimetidine after evening meal. Dig Dis Sci 40: 2091–2097 (1995).

    CAS  PubMed  Google Scholar 

  309. Seitz HK, Bösche J, Czygan P, Veith S, Simon B, and Kommerell B. Increased blood ethanol levels following cimetidine but not ranitidine. Lancet 1:760 (1983).

    CAS  PubMed  Google Scholar 

  310. Seitz HK, Veith S, Czygan P, Bösche J, Simon B, Gugler R, and Kommerell B. In-vivo interactions between H2-receptor antaganists and ethanol metabolism in man and in rats. Hepatology 4:1231–1233 (1984).

    CAS  PubMed  Google Scholar 

  311. Feely J and Wood AJJ. Effects of cimetidine on the elimination and actions of ethanol. JAMA 247:2819–2821 (1982).

    CAS  PubMed  Google Scholar 

  312. Webster LK, Jones BD, and Smallwood RA. Influence of cimetidine and ranitidine on ethanol pharmacokinetics. Austr NZ J Med 15:359–360 (1985).

    CAS  Google Scholar 

  313. Dobrilla G, de Pretis G, Piazzi L, et al. Is ethanol metabolism affected by oral administration of cimetidine and ranitidine at therapeutic doses? Hepatogastroenterology 31:35–37 (1984).

    CAS  PubMed  Google Scholar 

  314. Jönsson K-A, Jones AW, Boström KL, and Andersson T. Lack of effect of omeprazole, cimetidine and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers. Eur J Clin Pharmacol 42:209–212 (1992).

    PubMed  Google Scholar 

  315. Fraser AG. Is there an interaction between H2-antagonists and alcohol? Drug Metabol Drug Interactions 14:123–145 (1998).

    CAS  Google Scholar 

  316. Crabbe DW. First-pass metabolism of ethanol; Gastric or hepatic: mountain or molehill. Gasterenterology 25:1292–1294 (1997).

    Google Scholar 

  317. Antkowiak B. How do general anaesthetic work? Naturwissenschaften 88:201–213 (2001).

    CAS  PubMed  Google Scholar 

  318. Urban BW and Bleckween M. Concepts and correlations relevant to general anaesthesia. Br J Anesth 89:3–16 (2002).

    CAS  Google Scholar 

  319. Little HJ. Mechanisms that may underlie the behavioural effects of ethanol. Prog Neurbiol 36:171–194 (1991).

    CAS  Google Scholar 

  320. Lüddens H, Pritchett DB, Köhler M, Killisch I, et al. Cerebellar GABA A receptor selective for a behavioural alcohol antagonist. Nature 346:648–651 (1990).

    PubMed  Google Scholar 

  321. Bormann J. The ABC of GABA receptors. Trends Pharmacol Sci 21:16–19 (2000).

    CAS  PubMed  Google Scholar 

  322. Pritchett DB, Sontheimer H, Shivers BD, Ymer S, et al. Importance of a novel GABA A receptor subunit for benzodiazepine pharmacology. Nature 338:582–585 (1989).

    CAS  PubMed  Google Scholar 

  323. Meheta AK and Ticku MK. An update on GABA A receptors. Brain Res Bull 29:196–217 (1999).

    Google Scholar 

  324. Rudolph U, Crestani F, and Möhler H. GABA A receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 22:188–194 (2001).

    CAS  PubMed  Google Scholar 

  325. Hobbs WR, Rall TW, and Verdoorn TA. Hypnotics and sedatives; ethanol. In: Goodman & Gilman’s The pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:361–396.

    Google Scholar 

  326. Byatt C and Volans G. ABC of poisoning: sedative and hypnotic drugs. Br Med J 289:1214–1217 (1984).

    CAS  Google Scholar 

  327. Gary NE and Tresznewsky O. Barbiturates and a potpourri of other sedative, hypnotics, and tranquilizers. Heart & Lung 12:122–127 (1983).

    CAS  Google Scholar 

  328. Bailey L, Ward M, and Musa MN. Clinical pharmacokinetics of benzodiazepines. J Clin Pharmacol 34:804–911 (1994).

    CAS  PubMed  Google Scholar 

  329. Johnson HRM. At what blood levels does alcohol kill? Med Sci Law 25:127–130 (1985).

    CAS  PubMed  Google Scholar 

  330. Odesanmi WO. The fatal blood alcohol level in acute poisoning. Med Sci Law 23:25–30 (1983).

    CAS  PubMed  Google Scholar 

  331. Kalant H. Research on tolerance: what can we learn from history. Alcohol Clin Exp Res 22:67–76 (1998).

    CAS  PubMed  Google Scholar 

  332. Mellanby E. Alcohol: its absorption into and disappearance from the blood under different conditions. Special report, Series No. 31, London: National Safety Council 1919.

    Google Scholar 

  333. Jones AW. The drunkest drinking driver in Sweden; blood alcohol concentration 0.545 % w/v. J Studies Alc 60:400–406 (1999).

    CAS  Google Scholar 

  334. Urso T, Gavaler JS, and Van Thiel DH. Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci 28:1053–1056 (1985).

    Google Scholar 

  335. Jones AW. Alcohol; post-mortem. In: Encyclopedia of forensic sciences. London: Academic Press, 2000:112–126.

    Google Scholar 

  336. Ward ME and Cowley AR. Hypothermia: a natural cause of death. Am J Forens Med Pathol 20:383–386 (1999).

    CAS  Google Scholar 

  337. Gallaher MM, Fleming DW, Berger LR, and Sewell CM. Pedestrian and hypothermia deaths among native Americans in New Mexico. JAMA 267:1345–2348 (1992).

    CAS  PubMed  Google Scholar 

  338. Kortelainen ML. Drugs and alcohol in hyporthermia and hypethermia related deaths. A retrospective study. J Forensic Sci 32:1704–1712 (1987).

    CAS  PubMed  Google Scholar 

  339. Kalant H and Le AD. Effects of ethanol on thermoregulation. Pharmacol Ther 23:313–364 (1984).

    Google Scholar 

  340. Larach MG. Accidential hypothermia. Lancet 345:493–498 (1995).

    CAS  PubMed  Google Scholar 

  341. Teige B and Fleischer E. Blodkonsentrasjoner ved akutte forgiftningsdodsfall. Tidsskr Nor Laegeforen 103:679–685 (1983).

    CAS  PubMed  Google Scholar 

  342. Thomsen JL, Theilade P, Felby S, and Nielsen E. Alcoholic ketoacidosis as a cause of death in forensic cases. Forens Sci Intern 75:163–171 (1995).

    CAS  Google Scholar 

  343. Thomsen JL. Various mechanisms of death and their possible association with alcoholism. Forens Sci Intern 79:199–204 (1996).

    CAS  Google Scholar 

  344. Pounder DJ, Stevenson RJ, and Taylor KK. Alcoholic ketoacidosis at autopsy. J Forensic Sci 43:812–816 (1998).

    CAS  PubMed  Google Scholar 

  345. Brinkmann B, Fechner G, Karger B, and DuChesne A. Ketoacidosis and lactic acidosis—frequent causes of death in chronic alcoholics? Int J Leg Med 111:115–119 (1998).

    CAS  Google Scholar 

  346. Lahti RA and Vuori E. Fatal alcohol poisoning: medico-legal practices and mortality statistics. Forens Sci Intern 126:203–209 (2002).

    CAS  Google Scholar 

  347. Höjer J, Baehrendtz S, and Gustafsson L. Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period. J Intern Med 226:117–122 (1989).

    PubMed  Google Scholar 

  348. Buckley NA, Dawson AH, Whyte IM, and O’Connell DL. Relative toxicity of benzodiazepines in overdose. Br Med J 310:219–221 (1995).

    CAS  Google Scholar 

  349. Serfaty M and Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psyciatr 163:383–393 (1993).

    Google Scholar 

  350. Drummer OH and Ranson DL. Sudden death and benzodiazepines. Am J Forens Med Pathol 7:336–342 (1996).

    Google Scholar 

  351. Druid H, Holmgreen P, and Ahlner J. Flunitrazepam: an evaluation of use, abuse and toxicity. Forens Sci Intern 122:136–141 (2001).

    CAS  Google Scholar 

  352. Tanaka E. Toxicological interactions between alcohol and benzodiazepines. J Toxicol Clin Toxicol 40:69–75 (2002).

    CAS  PubMed  Google Scholar 

  353. Caplan YH, Ottinger WE, and Crooke CR. Therapeutic and toxic drug concentrations in post mortem. A six year study in the state of Maryland. J Anal Toxicol 7:225–230 (1983).

    CAS  PubMed  Google Scholar 

  354. Jonasson B, Jonasson U, and Saldeen T. The manner of death among fatalities where dextropropoxyphene caused or contributed to death. Forens Sci Intern 96:181–187 (1998).

    CAS  Google Scholar 

  355. Jonasson U, Jonasson B, Holmgren P, and Saldeen T. The prevalence of dextropropoxyphene in autopsy blood samples. Forens Sci Intern 96:135–142 (1998).

    CAS  Google Scholar 

  356. Sturner WQ and Garriott JC. Deaths involving propoxyphene: a study of 41 cases over a two-year period. JAMA 223:1125–1130 (1973).

    CAS  PubMed  Google Scholar 

  357. Buckley BM and Vale JA. Dextropropoxyphene poisoning: problems with interpretation of analytical data. Hum Toxicol 3:95–101 (1984).

    Google Scholar 

  358. Young RJ. Dextropropoxyphene overdosage: pharmacological considerations and clinical management. Drugs 26:70–79 (1983).

    CAS  PubMed  Google Scholar 

  359. Finkle BS, Caplan YH, Garriott JC, Montforte JR, Shaw RF, and Sonsalla PK. Propoxyphene in postmortem toxicology 1976–1978. J Forensic Sci 26:739–757 (1981).

    CAS  PubMed  Google Scholar 

  360. Finkle BS. Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds. Hum Toxicol Supp 115S–134S (1984).

    Google Scholar 

  361. Tallman JF, Paul SM, Skolnick P, and Gallager DW. Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science 207:274–281 (1980).

    CAS  PubMed  Google Scholar 

  362. Koski A, Ojanpera I, and Vuori E. Alcohol and benzodiazepines in tatal poisonings. Alcohol Clin Exp Res 26:956–959 (2002).

    PubMed  Google Scholar 

  363. Drummer OK, Syrjanen ML, and Cordner SM. Deaths involving the benzodiazepine flunitrazepam. Am J Forens Med Pathol 14:238–243 (1993).

    CAS  Google Scholar 

  364. Carmen Del Rio M, Prada C, and Alvarez FJ. Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines? Alcohol 26:31–34 (2002).

    PubMed  Google Scholar 

  365. Fraser AD. Use and abuse of the benzodiazepines. Therap Drug Monitor 20:481–489 (1998).

    CAS  Google Scholar 

  366. Stead AH and Moffatt AC. Quantification of the interaction between barbiturates and alcohol at different concentrations. Hum Toxicol 2:5–14 (1983).

    CAS  PubMed  Google Scholar 

  367. Stead AH, Allan AR, Ardrey RE, Bal TS, Callaghan TM, Gill R, et al. Drug misuse—the barbiturate problem. J Forens Sci Soc 21:41–53 (1981).

    CAS  Google Scholar 

  368. Möhler H, Fritschy JM, and Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Therap 300:2–9 (2002).

    Google Scholar 

  369. George CFP. Pyrazolopyrimidines. Lancet 358:1623–1626 (2001).

    CAS  PubMed  Google Scholar 

  370. Laurijssens BE and Greenblatt DJ. Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin Pharmacokinet 30:52–76 (1996).

    CAS  PubMed  Google Scholar 

  371. Mandelli M, Tognono G, and Gerattini S. Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3:72–91 (1978).

    CAS  PubMed  Google Scholar 

  372. Greenblatt DJ, Harmatz JS, Friedman H, Locnisker A, and Shader RI. A large sample study of diazepam pharmacokinetics. Therap Drug Monitor 11:652–657 (1989).

    CAS  Google Scholar 

  373. Greenblatt DJ, Laughren TP, Allen MD, Harmatz JS, and Shader RI. Plasma diazepam and desmethyldiazepam concentrations during long term diazepam therapy. Br J Clin Pharmacol 1:35–40 (1981).

    Google Scholar 

  374. Joynt BP. Triazolam blood concentrations in forensic cases in Canada. J Anal Toxicol 17: 171–177 (1993).

    CAS  PubMed  Google Scholar 

  375. Edwards JG. Medicolegal aspects of benzodiazepine dependence: duties and responsibilities of doctors. Med J Aust 156:733–737 (1992).

    CAS  PubMed  Google Scholar 

  376. Steentoft A, Teige B, Ceder G, Vuori E, Kristinsson E, Kaa J, et al. Fatal poisoning in drug addicts in the Nordic countries. Forens Sci Intern 123:63–69 (2001).

    CAS  Google Scholar 

  377. Steentoft A and Worm K. Cases of fatal triazolam poisoning. J Forensic Sci Soc 33:45–48 (1993).

    CAS  PubMed  Google Scholar 

  378. Sunter JP, Bal TS, and Cowan WK. Three cases of fatal triazolam poisoning. Br Med J 297: 719 (1998).

    Google Scholar 

  379. Finkle BS, McCloskey KL, and Goodman LS. Diazepam and drug-associated deaths. JAMA 242:429–434 (1979).

    CAS  PubMed  Google Scholar 

  380. Costa E and Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 17:192–200 (1996).

    CAS  PubMed  Google Scholar 

  381. Garretty DJ, Wolff K, Hay AWM, and Raistrick D. Benzodiazepine misuse by drug addicts. Ann Clin Biochem 34:68–73 (1997).

    CAS  PubMed  Google Scholar 

  382. Woods JH, Katz JL, and Winger G. Abuse liability of benzodiazepines. Pharmacol Rev 39: 251–419 (1987).

    CAS  PubMed  Google Scholar 

  383. Woods JH, Katz JL, and Winger G. Benzodiazepines: use, abuse and consequences. Pharmacol Rev 44:151–347 (1992).

    CAS  PubMed  Google Scholar 

  384. Woods JH and Wingler G. Abuse liability of flunitrazepam. J Clin Psychopharmacol 17: 1S-57S (1997).

    CAS  PubMed  Google Scholar 

  385. Bertilsson L, Baillie TA, and Reviriego J. Factors influencing the metabolism of diazepam. Pharmacol Ther 45:85–91 (1990).

    CAS  PubMed  Google Scholar 

  386. Laisi U, Linnoila M, Seppäla T, Himberg I-J, and Mattila MJ. Pharmacokinetic and pharmacodynamic interactions of diazepam with different alcoholic beverages. Eur J Clin Pharmacol 16:263–270 (1979).

    CAS  Google Scholar 

  387. Friedman H, Greenblatt DJ, Peters GR, Metzler CM, Charlton MD, Marmatz JS, et al. Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and time. Clin Pharmacol Ther 52:139–150 (1992).

    CAS  PubMed  Google Scholar 

  388. Greenblatt DJ, Allen MD, Harmatz JS, and Shader RI. Diazepam disposition determinants. Clin Pharmacol Ther 27:301–312 (1980).

    CAS  PubMed  Google Scholar 

  389. Jonasson B and Saldeen T. Citalopram in fatal poisoning cases. Forens Sci Intern 126:1–6 (2002).

    CAS  Google Scholar 

  390. Worm K, Dragsholt C, Simonsen K, and Kringsholm B. Citalopram concentrations in samples from autopsies and living persons. Int J Legal Med 111:188–190 (1998).

    CAS  PubMed  Google Scholar 

  391. Bailey DN and Shaw RF. Interpretation of blood and tissue concentrations in fatal selfpoisoning overdoses involving amitriptyline: an update 1978–1979. J Anal Toxicol 4:232–236.

    Google Scholar 

  392. Gruchalla RS. Clinical assessment of drug-induced disease. Lancet 356:1505–1511 (2000).

    CAS  PubMed  Google Scholar 

  393. Pennings EJM, Leccese AP, and de Wolff FA. Effects of concurrent use of alcohol and cocaine. Addiction 97:773–779 (2002).

    PubMed  Google Scholar 

  394. Farre M, de la Torre R, Gonzalez ML, Teran MT, Roset PN, Menoyo E, and Cami J. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Therap 283:164–176 (1997).

    CAS  Google Scholar 

  395. Hearn WL, Rose S, Wagner J, Ciarleglio A, and Mash DC. Cocatheylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 39:531–533 (1991).

    CAS  PubMed  Google Scholar 

  396. McCance EF, Price LH, Kosten TR, and Jatlow P. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Therap 274:215–223 (1995).

    CAS  Google Scholar 

  397. Andrews P. Cocaethylene toxicity. J Addict Dis 16:75–84 (1997).

    CAS  PubMed  Google Scholar 

  398. Bailey DN. Serial plasma concentrations of cocoethylene, cocaine, and ethanol in trauma victims. J Anal Toxicol 17:79–83 (1993).

    CAS  PubMed  Google Scholar 

  399. Bailey DN. Comprehensive review of cocaethylene and cocaine concentrations in patients. Am J Clin Pathol 106:701–704 (1996).

    CAS  PubMed  Google Scholar 

  400. Jatlow P. Cocaethylene. Pharmacologic activity and clinical significance. Therap Drug Monitor 15:533–536 (1993).

    CAS  Google Scholar 

  401. Jatlow P, McChance EF, Bradberry CW, Elsworth JD, Taylor JR, and Roth RH. Alcohol plus cocaine: the whole is more than the sum of its parts. Therap Drug Monitor 18:460–464 (1996).

    CAS  Google Scholar 

  402. Sharpe PC. Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem 38:652–664 (2001).

    CAS  PubMed  Google Scholar 

  403. Johnson BA and Ait-Daoud N. Medications to treat alcoholism. Alc Res Health 23:99–105 (1999).

    CAS  Google Scholar 

  404. Garbutt JC, West SL, Carey TS, Lohr KN, and Crews FT. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281:1318–1325 (1999).

    CAS  PubMed  Google Scholar 

  405. Kreek MJ, LaForge KS, and Butelman E. Pharmacotherapy of addictions. Nature Rev Drug Disc 1:710–726 (2002).

    CAS  Google Scholar 

  406. Sellers EM and Kalant H. Alcohol intoxication and withdrawal. N Engl J Med 294:757–762 (1976).

    PubMed  Google Scholar 

  407. Johnsen J, Stowell A, Stensrud T, Ripel A, and Morland J. A double-blind placebo controlled study of healthy volunteers given a subcutaneous disulfiram implantation. Pharmacol Toxicol 66:227–230 (1990).

    CAS  PubMed  Google Scholar 

  408. Swift RM. Effect of naltrexone on human alcohol consumption. J Clin Psychiatry 56(Suppl 7):24–29 (1995).

    PubMed  Google Scholar 

  409. Krystal JH, Cramer JA, Krol WF, Kirk GF, and Rosenheck RA. Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734–1739 (2001).

    CAS  PubMed  Google Scholar 

  410. Swift RM. Medications and alcohol craving. Alc Res Health 23:207–213 (1999b).

    CAS  Google Scholar 

  411. Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gallimberti L, et al. Pharmacokinetics of gamma-hydroxybutyrate in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol 34:231–235 (1992).

    CAS  PubMed  Google Scholar 

  412. Carai MAM, Colombo G, Reali R, Serra S, et al. Central effects of 1,4 butanediol are mediated by GABA B receptors via its conversion into y-hydroxybutyric acid. Eur J Pharmacol 441:157–163 (2002).

    CAS  PubMed  Google Scholar 

  413. Swift RM, Davidson D, Whelihan W, and Kuznetsov O. Ondansetron alters human alcohol metabolism. Biol Psychiatry 15:514–521 (1996).

    Google Scholar 

  414. Swift RM. Drug therapy for alcohol dependence. N Engl J Med 340:1482–1490 (1999a).

    CAS  PubMed  Google Scholar 

  415. Schneble H. Ernüchterungsmittel—nüüchtern betrachtet. Blutalkohol 25:18–65 (1988).

    CAS  PubMed  Google Scholar 

  416. Linnoila M and Mattila MJ. How to antagonize ethanol-induced inebrieation. Pharmacol Ther 15:99–109 (1981).

    CAS  PubMed  Google Scholar 

  417. Lister R and Nutt DJ. Is RO 15–4513 a specific alcohol antagonist? Trends Neur Sci 10: 223–225 (1987).

    CAS  Google Scholar 

  418. Allan AN and Harris RA. A new alcohol antagonist: phaclofen. Life Sci 45:1771–1779 (1989).

    CAS  PubMed  Google Scholar 

  419. Jones AW. Forensic science aspects of ethanol metabolism. Forens Sci Prog 5:33–90 (1991).

    Google Scholar 

  420. Wiese JG, Shlipak MG, and Browner WS. The alcohol hangover. Ann Intern Med 132: 897–902 (2000).

    CAS  PubMed  Google Scholar 

  421. Mascord D, Smith J, Starmer GA, and Whitfield JB. Effect of oral glucose on the rate of metabolism of ethanol in humans. Alc Alcohol 23:365–370 (1988).

    CAS  Google Scholar 

  422. Mascord D, Smith J, Starmer GA, and Whitfield JB. The effect of fructose on alcohol metabolism and on the lactate/pyruvate ratio in man. Alc Alcohol 26:53–59 (1991).

    CAS  Google Scholar 

  423. Rogers J, Smith J, Starmer GA, and Whitfield JB. Differing effects of carbohydrates, fat and protein on the rate of ethanol metabolism. Alc Alcohol 22:345–353 (1987).

    CAS  Google Scholar 

  424. Clark ER, Hughes IE, and Letley E. The effect of oral administration of various sugars on blood ethanol concentration in man. J Pharm Pharmacol 25:309–323 (1973).

    Google Scholar 

  425. Ylikahri RH, Leino T, Huttunen MO, Poso AR, Eriksson CJ, and Nikkila EA. Effects of fructose and glucose on ethanol-induced metabolic changes and on the intensity of alcohol intoxication and hangover. Eur J Clin Invest 6:93–102 (1976).

    CAS  PubMed  Google Scholar 

  426. Crow KE, Newland KM, and Batt RD. The fructose effect. NZ Med J 93:232–234 (1981).

    CAS  Google Scholar 

  427. Bode C. The metabolism of alcohol: physiological and pathological aspects. J Roy Coll Phys 12:122–135 (1978).

    CAS  Google Scholar 

  428. Cohen RD. Effect of fructose on blood alcohol level. Lancet 2:1086 (1972).

    CAS  PubMed  Google Scholar 

  429. Soterakis J and Iber FL. Increased rate of alcohol removal from blood with oral fructose and sucrose. Am J Clin Nut 28:254–257 (1975).

    CAS  Google Scholar 

  430. Polacsek P. Interaction of alcohol and other drugs an annotated bibliography. Toronto: Addiction Research Foundation, 1970:1–535.

    Google Scholar 

  431. Li J, Mills T, and Erato R. Intravenous saline has no effect on blood ethanol clearance. J Emerg Med 17:1–5 (1999).

    CAS  PubMed  Google Scholar 

  432. Hyvarinen J, Laakso M, Sippel H, Roine R, et al. Alcohol detoxification accelerated by oxygenated drinking water. Life Sci 22:553–560 (1978).

    CAS  PubMed  Google Scholar 

  433. Ylikahri R and Leino T. Metabolic interactions of xylitol and ethanol in healthy males. Metabolism 28:25–29 (1979).

    CAS  PubMed  Google Scholar 

  434. Alkana RL, Parker ES, Cohen HB, Birch H, and Nobel EP. Interaction of sted-eze, nikethamide, pipradrol, or ammonium chloride with ethanol in human males. Alcohol Clin Exp Res 4:84–92 (1980).

    CAS  PubMed  Google Scholar 

  435. Kelly M, Myrsten AL, and Goldberg L. Intravenous vitamins in acute alcoholic intoxication: effects on physiological and psychological functions. Br J Addict 66:19–30 (1971).

    CAS  Google Scholar 

  436. Chen MF, Boyce Worth H, and Hsu JM. Effect of ascorbic acid on alcohol clearance. J Am Coll Nutrit 9:185–189 (1990).

    CAS  Google Scholar 

  437. Susick RL and Zannoni VG. Effect of ascorbic acid on the consequences of acute alcohol consumption in humans. Clin Pharmacol Ther 41:502–509 (1987).

    PubMed  Google Scholar 

  438. Linnoila M, Mattila MJ, Karhunen P, Nuotto E, and Seppala T. Failure of TRH and ORG 2766 hexapeptide to counteract alcoholiic inebriation in man. Eur J Clin Pharmacol 21: 27–32 (1981).

    CAS  PubMed  Google Scholar 

  439. Kraemer R, Mallach HJ, Raff G, and Schulz H. Influence of mobiletten on the effect of alcohol drinking in man. Int J Clin Pharmacol 15:301–309 (1977).

    CAS  Google Scholar 

  440. Mallach HJ, Raff G, and Kraemer R. On the influence of mobiletten on the effect of alcohol in the human. Int J Clin Pharmacol 15:576–580 (1977).

    CAS  Google Scholar 

  441. Miller LG. Herbal medicines: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158:2200–2211 (1998).

    CAS  PubMed  Google Scholar 

  442. Azcona O, Barbanol MJ, Torrent J, and Jane F. Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 40:393–400 (1993).

    Google Scholar 

  443. Liguori A and Robinson JH. Caffeine antagonism of alcohol-induced driving impairment. Drug Alc Depend 63:123–129 (2001).

    CAS  Google Scholar 

  444. Shoaf SE and Linnoila M. Interaction of ethanol and smoking on the pharmacokinetics and pharmacodynamics of psychotropic medications. Psychopharm Bull 27:577–594 (1991).

    CAS  Google Scholar 

  445. Mendelson J, Jones RT, Upton R, and Jacob P. Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther 57:559–568 (1995).

    CAS  PubMed  Google Scholar 

  446. Mattila MJ, Kuitunen T, and Pletan Y. Lack of pharmacodynamic and pharmacolkinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol 43:179–184 (1992).

    CAS  PubMed  Google Scholar 

  447. Lader M, Melhuish A, Frcka G, Fredricson Overo K, and Christensen V. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 31:183–190 (1986).

    CAS  PubMed  Google Scholar 

  448. Van Harten J, Stevens LA, Raghoebar M, Holland RL, et al. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 52:427–435 (1992).

    PubMed  Google Scholar 

  449. Naranjo CA, Sullivan JT, Kadlec KE, Woodley-Remus DV, Kennedy G, and Sellers EM. Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 46:301–309 (1989).

    CAS  PubMed  Google Scholar 

  450. Anton R, Paladino JA, Morton A, and Thomas RW. Effect of acute alcohol consumption on lithium kinetics. Clin Pharmacol Ther 38:52–55 (1985).

    CAS  PubMed  Google Scholar 

  451. Dole VP, Fishman J, Goldfrank L, Khanna J, and McGivern RF. Arousal of ethanol-intoxicated comatose patients with naloxone. Alcohol Clin Exp Res 6:275–279 (1982).

    CAS  PubMed  Google Scholar 

  452. Bodd E, Beylich M, Christophersen A, and Morland J. Oral administration of codeine in the presence of ethanol: a pharmacokinetic study in man. Pharmacol Toxicol 61:297–300 (1987).

    CAS  PubMed  Google Scholar 

  453. Donnelly B, Balkon J, Lasher C, DePaul Lynch V, et al. Evaluation of the methadone—alcohol interaction. 1. Alterations of plasma concentration kinetics. J Anal Toxicol 7:246–248 (1983).

    CAS  PubMed  Google Scholar 

  454. Griffin JP, D’Arcy PF, and Speirs CJ. A manual of adverse drug interactions, 4th ed. London: Wright, 1988.

    Google Scholar 

  455. Logan BK and Distefano S. Ethanol content of various foods and soft drinks and their potential for interference with a breath-alcohol test. J Anal Tox 22:181–183 (1998).

    CAS  Google Scholar 

  456. Baum CR, Shannon MW, and Woolf A. Breath and blood ethanol following use of a coughcold preparation. J Tox Clin Tox 35:643–644 (1997).

    CAS  Google Scholar 

  457. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, and MacDonald TM. Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331–1336 (1998).

    CAS  PubMed  Google Scholar 

  458. Druid H and Holmgren P. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79–87 (1997).

    PubMed  Google Scholar 

  459. Li T-K. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. J Studies Alc 61:5–12 (2000).

    CAS  Google Scholar 

  460. Nestler EJ. Genes and addiction. Nature Med 26:277–281 (2000).

    CAS  Google Scholar 

  461. Kalow W. Pharmacogenetics in biological perspective. Pharmacol Rev 49:369–379 (1997).

    CAS  PubMed  Google Scholar 

  462. Ingelman-Sundberg M. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120:259–268 (2001).

    CAS  PubMed  Google Scholar 

  463. Knowles SR, Uetrecht J, and Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndrome. Lancet 356:1587–1591 (2000).

    CAS  PubMed  Google Scholar 

  464. Pirmohamed M and Park BK. Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci 22:298–305 (2001).

    CAS  PubMed  Google Scholar 

  465. Nebert DW. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants. Clin Chem Lab Med 38:857–861 (2000).

    CAS  PubMed  Google Scholar 

  466. Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet 359:1667–1671 (2000).

    Google Scholar 

  467. Ingelman-Sundberg M. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J Intern Med 250:186–200 (2001).

    CAS  PubMed  Google Scholar 

  468. Li T-K, Yin SJ, Crabb DW, O’Connor S, and Ramchandani VA. Genetic and environmental influences on alcohol metabolism in humans. Alcohol Clin Exp Res 25:136–144 (2001).

    CAS  PubMed  Google Scholar 

  469. Vesell ES, Page JG, and Passananti GT. Genetic and environmental factors affecting ethanol metabolism in man. Clin Pharmacol Ther 12:192–201 (1971).

    CAS  PubMed  Google Scholar 

  470. Baselt RC and Cravey RH. Disposition of toxic drugs and chemicals in man, 4th ed. Foster City, CA: Chemical Toxicology Institute, 1995.

    Google Scholar 

Download references

Authors
  1. A. Wayne Jones PhD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harris County Medical Examiner Office, Houston, TX, USA

    Ashraf Mozayani PharmD, PhD

  2. University of Miami School of Medicine, Miami, FL, USA

    Lionel P. Raymon PharmD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jones, A.W. (2004). Alcohol and Drug Interactions. In: Mozayani, A., Raymon, L.P. (eds) Handbook of Drug Interactions. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-654-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-654-6_12

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-424-1

  • Online ISBN: 978-1-59259-654-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation